Search research articles
Contact Us
Filters
Showing results (201-210 of 925) with videos related to
Page
of 93
Sort By:
Anticancer Research
|
August 19, 2007
Cytotoxic effects of treosulfan on prostate cancer cell lines
Susan Feyerabend, Gerhard Feil, Jutta Krug, et al.
Medical Hypotheses
|
June 1, 2016
Systemic anti-CTLA-4 and intravesical Bacille-Calmette-Guerin therapy in non-muscle invasive bladder cancer: Is there a rationale of synergism?
Omar Fahmy, Mohd Ghani Khairul-Asri, Arnulf Stenzl, et al.
Clinical & Experimental Metastasis
|
July 7, 2016
The current status of checkpoint inhibitors in metastatic bladder cancer
Omar Fahmy, Mohd Ghani Khairul-Asri, Arnulf Stenzl, et al.
Der Urologe. Ausg. A
|
November 12, 2015
[Leiomyomatous renal cell carcinoma : Controversy around a new entity]
S Rausch, M Scharpf, H Moch, et al.
Future Oncology (London, England)
|
June 25, 2020
Enzalutamide plus androgen-deprivation therapy in hormone-sensitive prostate cancer: new perspectives from a current Phase III clinical trial
Valentina Norz, Laura Lawaczeck, Jens Bedke, et al.
Asian Journal of Andrology
|
January 18, 2011
A self-reported long-term follow-up of patients operated with either shortening techniques or a TachoSil grafting procedure
Marcus Horstmann, Matthias Kwol, Bastian Amend, et al.
European Urology
|
June 6, 1998
Anterior exenteration with subsequent ureteroileal urethrostomy in females. Anatomy, risk of urethral recurrence, surgical technique, and results
A Stenzl, K Colleselli, S Poisel, et al.
Clinical Genitourinary Cancer
|
July 13, 2015
Feasibility of Penis-Preserving Surgery for Urethral Melanoma: Proposal for a Therapeutic Algorithm
Omar Fahmy, Marcus Scharpf, Falko Fend, et al.
Der Urologe. Ausg. A
|
February 23, 2018
[Current guideline-oriented follow-up of small renal masses : Applied risk scores and future outlook]
V Stühler, S Kruck, T Todenhöfer, et al.
Der Urologe. Ausg. A
|
March 23, 2016
[Urinary bladder injuries. Diagnosis and treatment]
S Rausch, B Amend, M Adam, et al.
Page
of 93
Search research articles
Search
Showing results (201-210 of 925) with videos related to
Sort By:
Page
of 93
Anticancer Research
|
August 19, 2007
Cytotoxic effects of treosulfan on prostate cancer cell lines
Susan Feyerabend, Gerhard Feil, Jutta Krug, et al.
Medical Hypotheses
|
June 1, 2016
Systemic anti-CTLA-4 and intravesical Bacille-Calmette-Guerin therapy in non-muscle invasive bladder cancer: Is there a rationale of synergism?
Omar Fahmy, Mohd Ghani Khairul-Asri, Arnulf Stenzl, et al.
Clinical & Experimental Metastasis
|
July 7, 2016
The current status of checkpoint inhibitors in metastatic bladder cancer
Omar Fahmy, Mohd Ghani Khairul-Asri, Arnulf Stenzl, et al.
Der Urologe. Ausg. A
|
November 12, 2015
[Leiomyomatous renal cell carcinoma : Controversy around a new entity]
S Rausch, M Scharpf, H Moch, et al.
Future Oncology (London, England)
|
June 25, 2020
Enzalutamide plus androgen-deprivation therapy in hormone-sensitive prostate cancer: new perspectives from a current Phase III clinical trial
Valentina Norz, Laura Lawaczeck, Jens Bedke, et al.
Asian Journal of Andrology
|
January 18, 2011
A self-reported long-term follow-up of patients operated with either shortening techniques or a TachoSil grafting procedure
Marcus Horstmann, Matthias Kwol, Bastian Amend, et al.
European Urology
|
June 6, 1998
Anterior exenteration with subsequent ureteroileal urethrostomy in females. Anatomy, risk of urethral recurrence, surgical technique, and results
A Stenzl, K Colleselli, S Poisel, et al.
Clinical Genitourinary Cancer
|
July 13, 2015
Feasibility of Penis-Preserving Surgery for Urethral Melanoma: Proposal for a Therapeutic Algorithm
Omar Fahmy, Marcus Scharpf, Falko Fend, et al.
Der Urologe. Ausg. A
|
February 23, 2018
[Current guideline-oriented follow-up of small renal masses : Applied risk scores and future outlook]
V Stühler, S Kruck, T Todenhöfer, et al.
Der Urologe. Ausg. A
|
March 23, 2016
[Urinary bladder injuries. Diagnosis and treatment]
S Rausch, B Amend, M Adam, et al.
Page
of 93